Price (90d)
No price history yet — the daily price refresh runs once a day.
Signal Score (90d)
50Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $1.42B | $9.66M | $0.03 |
| 2024 | $1.25B | $-57.44M | $-0.15 |
| 2023 | $1.06B | $-186.26M | $-0.51 |
| 2022 | $859.54M | $-215.56M | $-0.61 |
| 2021 | $667.51M | $-307.20M | $-1.05 |
Social Signal Score
Earnings
Thu, Nov 5(in 3 months)
Consensus estimate $0.03 per share
Typical surprise +93.9% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, Aug 6$0.06 vs $0.03beat
- Thu, May 7$0.04 vs $0.01beat
- Wed, Feb 25$0.03 vs $-0.00beat
- Thu, Nov 6$0.00 vs $-0.01beat
- Thu, Aug 7$-0.01 vs $-0.03beat
- Wed, May 7$0.00 vs $-0.04beat
Estimates and results for LFST via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Valuation
Project earnings forward and see what return today's price implies.
EPS was negative in at least one boundary year, so a compound growth rate can't be computed from it. Set your own assumption.
- EPS in 5 years
- $0.04
- Implied price
- $0.66
- Return from $12.42
- -44.4% a year
To earn 15.0% a year on these assumptions you'd need to buy at $0.33 — -97.3% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 12 | 15 | 18 | 21 | 24 |
|---|---|---|---|---|---|
| -2.0% | -53.4% | -51.3% | -49.5% | -47.9% | -46.5% |
| 3.0% | -51.1% | -48.8% | -46.9% | -45.3% | -43.8% |
| 8.0% | -48.7% | -46.4% | -44.4% | -42.6% | -41.1% |
| 13.0% | -46.3% | -43.9% | -41.8% | -40.0% | -38.3% |
| 18.0% | -43.9% | -41.4% | -39.2% | -37.3% | -35.6% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Mentions (6)
- Newszacks.com·2d ago·Neutral
LifeStance Health Group (LFST) Is Up 3.44% in One Week: What You Should Know Does LifeStance Health Group (LFST) have what it takes to be a top stock pick for momentum investors? Let's find out.
View source ↗ - Newszacks.com·3d ago·Positive
5 Low-Leverage Stocks to Buy as High Oil Prices Shake Investor Confidence High oil prices and market volatility spotlight five low-leverage stocks with strong earnings growth and resilient balance sheets.
View source ↗ - Newszacks.com·4d ago·Positive
LifeStance Health (LFST) Upgraded to Buy: Here's Why LifeStance Health (LFST) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
View source ↗ - Newszacks.com·4d ago·Positive
LifeStance Health Group, Inc. (LFST) Soars to 52-Week High, Time to Cash Out? LifeStance Health (LFST) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
View source ↗ - Newsprnewswire.com·4d ago·Neutral
LifeStance Survey Finds Women Want Mental Healthcare Built Into Perimenopause and Menopause Care One in Three Women Don't Know Perimenopause Can Cause Anxiety, Depression and Mood Changes; Majority Who Seek Mental Healthcare Find It Helpful SCOTTSDALE, Ariz., Aug. 11, 2026 /PRNewswire/ -- A LifeStance Health survey of 1,000 women experiencing perimenopause or menopause released today reveals this life stage carries an unexpected mental health toll, as one in three women (33%) report being unawa
View source ↗ - Newsdefenseworld.net·4d ago·Positive
LifeStance Health Group (NASDAQ:LFST) Sets New 1-Year High After Analyst Upgrade LifeStance Health Group, Inc. (NASDAQ: LFST - Get Free Report)'s stock price reached a new 52-week high during trading on Monday after BTIG Research raised their price target on the stock from $15.00 to $16.00. BTIG Research currently has a buy rating on the stock. LifeStance Health Group traded as high as $12.06 and last traded
View source ↗